 Loading
|
Take control of your epilepsy and seizures. Seizure management has never been easier.
TAKE CONTROL TODAYBanzel (rufinamide) is generally used as add-on (adjunctive) therapy for seizures associated with the Lennox-Gastaut syndrome that are not well controlled by other medications. These seizures may include simple partial, complex partial, secondarily generalized tonic-clonic, primarily generalized tonic-clonic, atonic, tonic, absence and myoclonic seizures. However, limited experience with Banzel is available for some of these specific seizure types.
Studies of Banzel leading to approval showed an overall 33% reduction in total seizures, and a 43% reduction in tonic and atonic seizures. Not everyone taking the medicine showed an improvement, but more did than those adding on a sugar pill to their other medications.
Welcome to the Wiki. This space is created for epilepsy.com members to share their own experiences and expertise to help refine and expand the discussion around important topics.
No members have yet contributed to this topic. If you are not yet an epilepsy.com member, register today to get started on this Wiki topic and the many other advantages of being a member. If you are a member and wish to be the first to edit this Wiki topic, please make sure to login, then click on the orange "Start Wiki" button at the top of this page. Or, learn more about Wikis.